|
Re: Time Dependent Improvement in Survival for Women w/ Multiple Her2+ Brain Metastas
This post got bumped up due to spam, but I am amazed that science is progressing beyond Herceptin, Chemotherapy and Tykerb as treatments for brain mets. With TDM1, Pertuzamab, Intrathecal Herceptin, and others in the pipeline I hope that we can look back in another 2 1/2 years and see survival times measured in years and decades, instead of days.
Still back then Herceptin, Tykerb and Chemo improved survival from 148 days to 540 days.
I am grateful for the women who are participating in the trials so we can have access to more treatment choices.
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes
Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"
Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla
Reconstruction: TRAM flap, partial loss, Revision
The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
|
Linear Mode
